Aclaris Therapeutics Inc.

NASDAQ: ACRS · Real-Time Price · USD
1.84
0.15 (8.88%)
At close: Aug 15, 2025, 11:40 AM

Aclaris Therapeutics Revenue

Aclaris Therapeutics reported an annual revenue of $18.72M, reflecting a -40.09% growth. For the quarter ending June 30, 2025, Aclaris Therapeutics generated $1.78M in revenue.
Revenue (ttm)
18.72M
Revenue Growth
-40.09%
Price / Sales Ratio
10.24
Revenue / Employee
306.89K
Employees
61
Market Cap
199.87M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.